| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/07/1999 | EP0927556A1 Dosage units of steroids with a seal coating for the steroids |
| 07/07/1999 | EP0927555A1 Use of cyclooxygenase-2 inhibitors for the treatment and prevention of tumors, tumor-related disorders and cachexia |
| 07/07/1999 | EP0927554A2 Cosmetic composition for skin comprising urea |
| 07/07/1999 | EP0927217A1 Angiogenic inhibitory compounds |
| 07/07/1999 | EP0927214A1 Polymerizable biodegradable polymers including carbonate or dioxanone linkages |
| 07/07/1999 | EP0927196A1 Polymers containing polysaccharides such as alginates or modified alginates |
| 07/07/1999 | EP0927192A1 Modified aminoacids, pharmaceuticals containing these compounds and method for their production |
| 07/07/1999 | EP0927184A1 3-substituted pyrido 4',3':4,5]thieno 2,3-d]pyrimidine derivatives, their preparation and their use |
| 07/07/1999 | EP0927183A1 Spirocyclic metalloprotease inhibitors |
| 07/07/1999 | EP0927182A2 Alkylated rapamycin derivatives |
| 07/07/1999 | EP0927181A1 Tricyclic compounds useful as fpt inhibitors |
| 07/07/1999 | EP0927180A1 Heterocyclic compounds and their use for isolating nucleic acids |
| 07/07/1999 | EP0927179A1 Substituted benzocycloheptapyridine derivatives useful for inhibition of farnesyl protein transferase |
| 07/07/1999 | EP0927178A1 Tricyclic compounds useful for inhibition of g-protein function and for treatment of proliferative diseases |
| 07/07/1999 | EP0927177A1 Novel benzothiophene derivatives, their preparation and use as urokinase inhibitors |
| 07/07/1999 | EP0927171A1 Pyrazinones and triazinones and their derivatives thereof |
| 07/07/1999 | EP0927170A1 Piperazino derivatives as neurokinin antagonists |
| 07/07/1999 | EP0927168A1 1,3-diheterocyclic metalloprotease inhibitors |
| 07/07/1999 | EP0927167A1 2-phenyl benzimidazole derivatives as mcp-1 antagonists |
| 07/07/1999 | EP0927166A1 Amides as npy5 receptor antagonists |
| 07/07/1999 | EP0927164A1 8-hydroxy-7-substituted quinolines as anti-viral agents |
| 07/07/1999 | EP0927163A1 Preparation of 1-butyl-4-piperidinylmethylamine |
| 07/07/1999 | EP0927161A1 Substituted cyclic amine metalloprotease inhibitors |
| 07/07/1999 | EP0927159A1 Polydithiocarbamate-containing macromolecules and the use thereof for therapeutic and diagnostic applications |
| 07/07/1999 | EP0927156A1 Biphenyl butyric acids and their derivatives as inhibitors of matrix metalloproteinases |
| 07/07/1999 | EP0927150A1 Lipoxin compounds and their use in treating cell proliferative disorders |
| 07/07/1999 | EP0927062A1 Skin battery cosmetic composition |
| 07/07/1999 | EP0927046A1 Mammalian regulator of nonsense-mediated rna decay |
| 07/07/1999 | EP0927045A2 Tumor homing molecules, conjugates derived therefrom, and methods of using same |
| 07/07/1999 | EP0927043A1 Method for gene transfer to the central nervous system |
| 07/07/1999 | EP0927040A1 Process to obtain oestrogens from mare's urine |
| 07/07/1999 | EP0927038A1 P1, p4-dithio-p2,p3-monochloromethylene 5', 5'''-diadenosine p1, p4-tetraphosphate as antithrombotic agent |
| 07/07/1999 | EP0927037A1 Chlorofluorocarbon-free mometasone furoate aerosol formulations |
| 07/07/1999 | EP0927036A1 Transdermal therapeutical approach involving a combination of active substances containing oestriol |
| 07/07/1999 | EP0927035A1 Thrombin inhibitors |
| 07/07/1999 | EP0927034A1 Method of treating urinary incontinence |
| 07/07/1999 | EP0927033A1 Retinoyloxy(substituted)alkylene butyrates useful for the treatment of cancer and other proliferative diseases |
| 07/07/1999 | EP0927032A1 Buccal, non-polar spray for nitroglycerin |
| 07/07/1999 | EP0927031A1 Pharmaceutical preparation containing nimesulide for oral administration |
| 07/07/1999 | EP0927030A1 Use of aryl n-substituted carboxamides to kill tumors |
| 07/07/1999 | EP0927029A1 Novel methods |
| 07/07/1999 | EP0927028A1 Use of sibutramine analogues to prevent the development of diabetes |
| 07/07/1999 | EP0927027A1 Use of 5-ht 4? antagonists for regulating corticosteroid secretion |
| 07/07/1999 | EP0927026A1 Pharmaceutical compositions containing amisulpride and their therapeutic applications |
| 07/07/1999 | EP0927024A2 Device and method for treating ophthalmic diseases |
| 07/07/1999 | EP0926954A1 Antimicrobial compositions |
| 07/07/1999 | EP0926951A1 Methods of treating pulmonary diseases mediated by polyunsaturated lipid metabolites and assays for epoxide hydrolase inhibitors |
| 07/07/1999 | EP0828492A4 Method for preventing intervention-associated stenosis following non-bypass, invasive interventions |
| 07/07/1999 | EP0822809A4 Controlled release formulation for water soluble drugs in which a passageway is formed in situ |
| 07/07/1999 | EP0805807B1 2-(2-amino-3-methoxyphenyl)-4-oxo-4h-(1)benzopyran for treating proliferative disorders |
| 07/07/1999 | EP0781130A4 Method for sleep induction |
| 07/07/1999 | EP0748329B1 3''-desmethoxy derivatives of erythromycin and azithromycin |
| 07/07/1999 | EP0701438B1 Gaba-ergic modulation of eye growth |
| 07/07/1999 | EP0689444B1 Tylosin containing sustained release veterinary compositions |
| 07/07/1999 | EP0636027B1 Angiotensin ii antagonists against disorders associated with impaired neuronal conduction velocity, especially diabetic neuropathy |
| 07/07/1999 | EP0609437B1 Novel sphingoglycolipid and use thereof |
| 07/07/1999 | EP0559774B1 Individual stereoisomers of 7- 3-(1-aminoalkyl)-1-pyrrolidinyl]-quinolones and naphthyridones as antibacterial agents |
| 07/07/1999 | EP0500807B1 Tissue moisturizing composition and method |
| 07/07/1999 | CN1222193A Extracellular matrix signalling molecules |
| 07/07/1999 | CN1222192A Antisense inhibitors of vascular endothelial growth factor (VEFG/VPF) expression |
| 07/07/1999 | CN1222160A Pregnane derivatives with no alpha-17 substitutent, their medicinal use, mfg. method and its intermediaries and related compounds |
| 07/07/1999 | CN1222159A 6,7-oxygenated steroids and uses related thereto |
| 07/07/1999 | CN1222154A Imidazole-substituted quinoxalinedione derivatives |
| 07/07/1999 | CN1222153A Piperidine acetic acid derivatives and their use in treatment of thrombotic disorders |
| 07/07/1999 | CN1222152A Indoline derivatives useful as 5-HT-2C receptor antagonists |
| 07/07/1999 | CN1222151A Cycloalkylaminomethylpyrrolidine derivatives |
| 07/07/1999 | CN1222149A Isocoumarin derivatives and use thereof in drugs |
| 07/07/1999 | CN1222146A Novel 'alpha;-hydroxylic acid derivatives, their prodn. and use |
| 07/07/1999 | CN1222145A Substituted benzamide derivatives and their use as anticonvulsants |
| 07/07/1999 | CN1222144A Distamycin derivatives, process for preparing them, and their use as antitumor and antiviral agents |
| 07/07/1999 | CN1222139A Polyol succinates and their pharmaceutical formulation |
| 07/07/1999 | CN1222081A Method for prevention and treatment of mastitis |
| 07/07/1999 | CN1222080A Cosmetic compsns. |
| 07/07/1999 | CN1222079A Oral pharmaceutical preparation containing ibandronat |
| 07/07/1999 | CN1222078A Hydroxy-phosphinyl derivatives useful as Naaladase inhibitors |
| 07/07/1999 | CN1222077A Fase-dissolving galanthamine hydrobromide tablet |
| 07/07/1999 | CN1222076A Use of green porphyrins in manufacture of medicament in treatment of atherosclerosis without purposeful irradiation of porphyrin derivatives |
| 07/07/1999 | CN1222075A Biconvex rapidly disintegrating dosage forms |
| 07/07/1999 | CN1222074A Administration regimen of H+, K+-ATPase inhibitors |
| 07/07/1999 | CN1221752A Novel lantibiotic related to actagardine, and process for preparation and use thereof |
| 07/07/1999 | CN1221743A Substituted heterocyclic benzoeycloalkenes and the use thereof as substances having analgesic effect |
| 07/07/1999 | CN1221734A New naphthalene compounds, process for their preparation and pharmaceutical compositions containing them |
| 07/07/1999 | CN1221730A Extraction and application of 10-hydroxyl-delta 2-decene acid |
| 07/07/1999 | CN1221627A Medicine for treating digestive system disease and its prepn. method |
| 07/07/1999 | CN1221620A Compound medicine for treating diabets mellitus |
| 07/07/1999 | CN1221609A Use of adenosine phosphates in preparation of medicaments and phamacentical formulations |
| 07/07/1999 | CN1221608A Synergistic combination of AIDS antiviral compounds and HIV inhibitor |
| 07/07/1999 | CN1043997C 2,6-diaminopurine derivatives, its use and medicinal compsns. containing same |
| 07/07/1999 | CN1043996C Antiparasitic agents and its prepn. method and use |
| 07/07/1999 | CN1043994C Thionaphthene diazepine compound, its prodn. method and application |
| 07/07/1999 | CN1043992C Process for prepn. of indolizine derivatives |
| 07/07/1999 | CN1043991C Qunazoline derivatives |
| 07/07/1999 | CN1043990C Imidazolidinone derivative, acid-addition salt therefor and remedy for senile dementia |
| 07/07/1999 | CN1043957C Method for prepn. of multi-unit dosage of oral medicine |
| 07/06/1999 | USRE36247 Method of hormonal treatment for menopausal or post-menopausal disorders involving continuous administration of progestogens and estrogens |
| 07/06/1999 | US5919960 Phytosphingosine-based ceramide I analogs |
| 07/06/1999 | US5919954 Stereoselective process for producing dihydro-2,3-benzodiazepine derivatives |
| 07/06/1999 | US5919943 Inhibition of spla2 |
| 07/06/1999 | US5919941 Intermediates for the preparation of sulphonic acid salts of 4-amino-2-cyclopentene-1-carboxylic acid |
| 07/06/1999 | US5919936 Nitropyridine compound |